Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Development and verification of a personalized immune prognostic feature in breast cancer.

Literature DB >> 32600059

Development and verification of a personalized immune prognostic feature in breast cancer.

Abstract

IMPACT STATEMENT: Breast cancer is among the highest prevalent malignant tumors worldwide with a low survival ratio. Immune-related genes have great potential as prognostic indicator in many types of tumors. Therefore, we have attempted to develop immune-related gene markers to enhance the prognosis of breast cancer. 17-IRGPs signature was constructed as a newly developed prognostic indicator to predict the survival of BC patients.

Entities: Disease Species

Keywords: Bioinformatics; IRGPs; TCGA; immune genes; prognostic markers

Mesh：

Substances：
Biomarkers, Tumor

Year: 2020 PMID： 32600059 PMCID： PMC7437380 DOI： 10.1177/1535370220936964

Source DB: PubMed Journal: Exp Biol Med (Maywood) ISSN： 1535-3699

53 in total

1. EZH2 and ALDH1 expression in ductal carcinoma in situ: complex association with recurrence and progression to invasive breast cancer.

Authors: Erik S Knudsen; Ornella Dervishaj; Celina G Kleer; Thomas Pajak; Gordon F Schwartz; Agnieszka K Witkiewicz
Journal: Cell Cycle Date: 2013-06-06 Impact factor: 4.534

2. Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma.

Authors: Bangrong Cao; Qifeng Wang; Huan Zhang; Guiquan Zhu; Jinyi Lang
Journal: Oncoimmunology Date: 2017-11-06 Impact factor: 8.110

3. Identification of the key genes implicated in the transformation of OLP to OSCC using RNA-sequencing.

Authors: Qiaozhen Yang; Bin Guo; Hongying Sun; Jie Zhang; Shangfeng Liu; Saiyin Hexige; Xuedi Yu; Xiaxia Wang
Journal: Oncol Rep Date: 2017-03-02 Impact factor: 3.906

4. Comparing the performance of visual estimation and standard uptake value of F-18 fluorodeoxyglucose positron emission tomography/computed tomography for detecting malignancy in pancreatic tumors other than invasive ductal carcinoma.

Authors: Yoichi Otomi; Hideki Otsuka; Kaori Terazawa; Hayato Nose; Michiko Kubo; Kenji Matsuzaki; Hitoshi Ikushima; Yoshimi Bando; Masafumi Harada
Journal: J Med Invest Date: 2014

5. Test set bias affects reproducibility of gene signatures.

Authors: Prasad Patil; Pierre-Olivier Bachant-Winner; Benjamin Haibe-Kains; Jeffrey T Leek
Journal: Bioinformatics Date: 2015-03-18 Impact factor: 6.937

6. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.

Authors: T Sørlie; C M Perou; R Tibshirani; T Aas; S Geisler; H Johnsen; T Hastie; M B Eisen; M van de Rijn; S S Jeffrey; T Thorsen; H Quist; J C Matese; P O Brown; D Botstein; P E Lønning; A L Børresen-Dale
Journal: Proc Natl Acad Sci U S A Date: 2001-09-11 Impact factor: 11.205

7. The Molecular Signatures Database (MSigDB) hallmark gene set collection.

Authors: Arthur Liberzon; Chet Birger; Helga Thorvaldsdóttir; Mahmoud Ghandi; Jill P Mesirov; Pablo Tamayo
Journal: Cell Syst Date: 2015-12-23 Impact factor: 10.304

8. Sorafenib in advanced hepatocellular carcinoma.

Authors: Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal: N Engl J Med Date: 2008-07-24 Impact factor: 91.245